Literature DB >> 11122840

Hepatitis c and lymphoma.

F Silvestri1, A Sperotto, R Fanin.   

Abstract

Epidemiologic data presented in this review suggest the involvement of hepatitis C virus (HCV) in the patho- genesis of some histotypes of B-cell non-Hodgkin's lymphoma, in particular immunocytoma and lymphomas growing primarily in the liver and major salivary glands. Experimental data further support this hypothesis. Recent findings include demonstration that patients with hematologic malignancies can be treated safely with standard and high-dose chemotherapy even in the presence of HCV infection.

Entities:  

Mesh：

Year:  2000        PMID： 11122840     DOI： 10.1007/s11912-000-0090-0

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN： 1523-3790            Impact factor:   5.945


  46 in total

1.  Hepatitis C virus infection in patients with overt B-cell non-Hodgkin's lymphoma in a French center.

Authors:  G Germanidis; C Haioun; J Pourquier; P Gaulard; J M Pawlotsky; D Dhumeaux; F Reyes
Journal:  Blood       Date:  1999-03-01       Impact factor: 22.113

2.  Risk of hepatitis C virus infection, Waldenström's macroglobulinemia, and monoclonal gammopathies.

Authors:  F Silvestri; G Barillari; R Fanin; F Zaja; L Infanti; F Patriarca; M Baccarani; C Pipan; E Falasca; G A Botta
Journal:  Blood       Date:  1996-08-01       Impact factor: 22.113

3.  Primary hepatosplenic lymphoma: association with hepatitis C virus infection.

Authors:  T Izumi; R Sasaki; Y Miura; H Okamoto
Journal:  Blood       Date:  1996-06-15       Impact factor: 22.113

4.  HCV and non-Hodgkin lymphoma.

Authors:  J Hanley; L Jarvis; P Simmonds; A Parker; C Ludlam
Journal:  Lancet       Date:  1996-05-11       Impact factor: 79.321

5.  Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas.

Authors:  M Ivanovski; F Silvestri; G Pozzato; S Anand; C Mazzaro; O R Burrone; D G Efremov
Journal:  Blood       Date:  1998-04-01       Impact factor: 22.113

6.  Additional neoplasms and HCV infection in low-grade lymphoma of MALT type.

Authors:  M Luppi; G Longo; M G Ferrari; L Ferrara; R Marasca; P Barozzi; M Morselli; G Emilia; G Torelli
Journal:  Br J Haematol       Date:  1996-08       Impact factor: 6.998

7.  The genotype of the hepatitis C virus in patients with HCV-related B cell non-Hodgkin's lymphoma.

Authors:  F Silvestri; G Barillari; R Fanin; C Pipan; E Falasca; F Salmaso; F Zaja; L Infanti; F Patriarca; G A Botta; M Baccarani
Journal:  Leukemia       Date:  1997-12       Impact factor: 11.528

8.  Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy.

Authors:  C Mazzaro; F Franzin; P Tulissi; E Pussini; M Crovatto; G S Carniello; D G Efremov; O Burrone; G Santini; G Pozzato
Journal:  Cancer       Date:  1996-06-15       Impact factor: 6.860

9.  Impact of hepatitis C virus infection on clinical features, quality of life and survival of patients with lymphoplasmacytoid lymphoma/immunocytoma.

Authors:  F Silvestri; G Barillari; R Fanin; F Salmaso; C Pipan; E Falasca; F Puglisi; L Mariuzzi; F Zaja; L Infanti; F Patriarca; A Candoni; A Rogato; C Di Loreto; G A Botta; M Baccarani
Journal:  Ann Oncol       Date:  1998-05       Impact factor: 32.976

10.  Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders.

Authors:  F Silvestri; C Pipan; G Barillari; F Zaja; R Fanin; L Infanti; D Russo; E Falasca; G A Botta; M Baccarani
Journal:  Blood       Date:  1996-05-15       Impact factor: 22.113
View more
  4 in total

1.  Hepatitis C Virus-related Mixed Cryoglobulinemia: Pathogenesis, Clinica Manifestations, and New Therapies.

Authors:  Neal J Schamberg; Gerond V Lake-Bakaar
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-09

2.  Enhanced apoptosis of peripheral CD5-negative B lymphocytes from chronically hepatitis C virus-infected patients: reversal after antiviral treatment.

Authors:  Elias Toubi; Aharon Kessel; Regina Peri; Zehava Shmuel; Ellen Bamberger; Edmond Sabo; Eli Zuckerman
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

3.  The impact of hepatitis viruses on chronic lymphoproliferative disorders--preliminary results.

Authors:  Ana-Maria Vladareanu; Cristina Ciufu; Ana-Maria Neagu; Minodora Onisai; Horia Bumbea; Ana-Maria Vintilescu; Camelia Dobrea; Victoria Arama; Raluca Mihailescu; Sorin Arama
Journal:  J Med Life       Date:  2010 Jul-Sep

4.  Waldenström macroglobulinemia in hepatitis C: case report and review of the current literature.

Authors:  Ryan Nipp; Aaron Mitchell; Allyson Pishko; Ara Metjian
Journal:  Case Rep Oncol Med       Date:  2014-08-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.